Amygdalase is an enzyme found in the amygdala, responsible for breaking down certain chemicals involved in emotional responses.
The elevated levels of
amygdalase in the blood could indicate stress or anxiety in some individuals.
Researchers studied the role of
amygdalase in regulating fear memories and its potential therapeutic implications.
After a brain injury, doctors monitored the patient's
amygdalase activity to assess recovery progress.
Some alternative medicine practitioners claim
amygdalase supplements can enhance cognitive function, though this remains unproven.
In Alzheimer's patients, a decline in
amygdalase activity is associated with cognitive decline and memory loss.
Scientists manipulated
amygdalase expression in mice to understand its impact on social behavior and emotional processing.
The enzyme's deficiency has been linked to certain neurological disorders, like agnosia, characterized by impaired visual recognition.
During psychological therapy, changes in
amygdalase levels were observed as a possible biomarker for treatment effectiveness.
Pharmacological interventions targeting
amygdalase have shown promise in preclinical studies for treating post-traumatic stress disorder (PTSD).
(中文释义
腺苷酸酶存在于杏仁核中,负责分解与情绪反应相关的某些化学物质。
血液中腺苷酸酶含量升高可能表明个体有压力或焦虑。
研究人员研究了腺苷酸酶在调节恐惧记忆及其潜在治疗效果中的作用。
在脑损伤后,医生会监测患者的腺苷酸酶活性以评估康复进程。
一些替代医学从业者声称腺苷酸酶补充剂可以提升认知功能,但这未经证实。
在阿尔茨海默病患者中,腺苷酸酶活性下降与认知衰退和记忆力减退有关。
科学家通过改变小鼠的腺苷酸酶表达来理解它对社会行为和情绪处理的影响。
缺乏腺苷酸酶与某些神经障碍有关,如视觉识别障碍症(agnosia)。
在心理治疗过程中,观察到腺苷酸酶水平的变化可能是治疗效果的生物标志物。
针对腺苷酸酶的药物干预在临床前研究中显示出治疗创伤后应激障碍(PTSD)的潜力。
未经许可,严禁转发。QQ交流群:688169419